MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$108,380
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from private offerings
    • Due to related parties, net
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Loan to related parties
    • Operating lease liabilities
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-810,481
-1,689,937
-3,016,463
-2,083,473
Depreciation
6,516
5,783
5,791
5,821
Stock-based compensation
253,041
787,374
1,386,213
1,136,217
Inventory write-down
-
-
11,460
-
Other non-cash expenses, net
-
-
7,843
25,963
Loss on investment in equity securities
-
-
-96,965
-
Other non-cash expenses
866
-
-
-
Loss on investment in equity securities
-24,766
-31,416
-652,979
-150,029
Loss on short-term investment
-36
-1,168
-
-
Amortization of right-of-use asset
82,979
86,373
208,252
90,190
Inventory
-
-
0
0
Prepaid expenses and other current assets
-107,622
-96,599
-4,414
2,281
Due from related parties
-109,771
133,778
-68,798
14,905
Accrued expenses and other current liabilities
45,663
-7,265
162,591
-33,632
Contract liabilities
-
-
-68,515
-
Tenant security deposit
22,090
9,077
-12,000
-29,575
Taxes payables
-5,945
-5,944
5,794
-17,351
Provision for doubtful accounts
-
-
0
-
Operating lease liabilities
-79,605
-75,109
-197,498
-95,919
Net cash used in operating activities
-244,413
-894,243
-587,582
-964,710
Proceeds from convertible notes payable third parties
-
-
490,000
0
Loan to related parties
147,572
-
86,670
511,112
Repayment of convertible notes payable third parties
-
-
0
277,284
Payment for long-term investment
-11,597
680,000
-
-
Prepayment from related parties
-
-
-
3,176
Repayment from related parties
-
-
203,026
-
Proceeds from convertible notes payable related parties
-
-
390,000
-
Payment for convertible notes receivable
-
32,000
-
-
Payment for convertible notes receivable- related party
32,000
-
-
-
Transaction costs for acquiring land
-
-
373
5,421
Repayment from related parties
-34,444
-759,123
150,000
-
Proceeds from convertible notes payable - related party
-
-
-
150,000
Net cash used in investing activities
-101,531
47,123
-29,654
-513,357
Repayment of short-term loans
29,649
661,650
30,119
31,406
Proceeds from related party payables
-
-
0
-
Proceeds from issuance of warrants
-
-
0
-
Repurchase of treasury stocks
-
-
0
-
Proceeds from private placement
-
-
528,183
908,370
Proceeds from issuance of a promissory note
-
-
0
-
Proceeds from exercise of warrants
0
102,000
0
579,699
Common stock subscription
-
319,492
-170,000
-
Proceeds from private offerings
319,492
-
-
-
Due to related parties, net
255,858
-57,554
-
-
Net cash provided by financing activities
226,209
-342,181
1,078,064
1,203,848
Effect of exchange rate changes on cash and cash equivalents and restricted cash
11,355
2,640
12,246
51,804
Net decrease in cash and cash equivalents and restricted cash
-108,380
-1,186,661
473,074
-222,415
Beginning
140,324
1,326,985
853,911
863,815
Ending
31,944
140,324
1,326,985
853,911
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from privateofferings$319,492 (-82.90%↓ Y/Y)Due to relatedparties, net$255,858 (675.36%↑ Y/Y)Net cash provided byfinancing activities$226,209 (-90.40%↓ Y/Y)Effect of exchange ratechanges on cash and cash...$11,355 (125.93%↑ Y/Y)Canceled cashflow$349,141 Net decrease in cashand cash...-$108,380 (-151.00%↓ Y/Y)Canceled cashflow$237,564 Stock-based compensation$253,041 (-84.38%↓ Y/Y)Due from relatedparties-$109,771 (-157.65%↓ Y/Y)Prepaid expenses andother current assets-$107,622 (-245.86%↓ Y/Y)Amortization of right-of-useasset$82,979 (-54.17%↓ Y/Y)Accrued expenses andother current...$45,663 (96.42%↑ Y/Y)Loss on investment inequity securities-$24,766 (74.15%↑ Y/Y)Tenant securitydeposit$22,090 (-10.60%↓ Y/Y)Depreciation$6,516 (-52.50%↓ Y/Y)Loss on short-terminvestment-$36 Repayment from relatedparties-$34,444 (-124.18%↓ Y/Y)something is missing$32,000 Payment for long-terminvestment-$11,597 something is missing-$319,492 Repayment of short-termloans$29,649 (-49.64%↓ Y/Y)Net cash used inoperating activities-$244,413 (82.96%↑ Y/Y)Canceled cashflow$652,484 Net cash used ininvesting activities-$101,531 (84.75%↑ Y/Y)Canceled cashflow$78,041 Net loss-$810,481 (75.27%↑ Y/Y)Operating leaseliabilities-$79,605 (56.03%↑ Y/Y)Taxes payables-$5,945 (-125.28%↓ Y/Y)Other non-cashexpenses$866 (-99.73%↓ Y/Y)Loan to relatedparties$147,572 (-81.74%↓ Y/Y)Payment for convertiblenotes receivable-...$32,000

ABVC BIOPHARMA, INC. (ABVC)

ABVC BIOPHARMA, INC. (ABVC)